Kilitch Drugs (India) Limited (NSE:KILITCH)
India · Delayed Price · Currency is INR 197.44
-3.10 (-1.55%)
Nov 11, 2026, 2:45 PM IST
Kilitch Drugs (India) Market Cap
Kilitch Drugs (India) has a market cap or net worth of 6.88 billion as of November 10, 2026. Its market cap has increased by 16.59% in one year.
Market Cap
6.88B
Enterprise Value
7.23B
Revenue
2.34B
Global Rank
n/a
Country Rank
n/a
PE Ratio
28.68
ChartMarket Cap Chart
Since March 5, 2002, Kilitch Drugs (India)'s market cap has increased from 14.33M to 6.88B, an increase of 47,920.48%. That is a compound annual growth rate of 28.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 6.88B | 21.98% |
| Dec 31, 2025 | 5.64B | 7.84% |
| Dec 31, 2024 | 5.23B | -12.48% |
| Dec 29, 2023 | 5.98B | 145.95% |
| Dec 30, 2022 | 2.43B | -37.79% |
| Dec 31, 2021 | 3.91B | 162.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sakar Healthcare | 22.85B |
| Indoco Remedies | 20.31B |
| Windlas Biotech | 20.06B |
| Beta Drugs | 19.07B |
| Anlon Healthcare | 14.31B |
| Jagsonpal Pharmaceuticals | 14.27B |
| Bafna Pharmaceuticals | 11.18B |
| Sigachi Industries | 10.39B |